Carbamazepine toxicity with concomitant levetiracetam therapy in patients with epilepsy
There is a temporal association between LEV administration and toxic blood levels and toxic symptoms of CBZ, the chances of which significantly higher when the dose ratio of LEV:CBZ is 1.86.
Authors
- Biswa Ranjan Mishra (ORCID: https://orcid.org/0000-0003-0537-9454)
- Debadatta Mohapatra (ORCID: https://orcid.org/0000-0001-7162-744X)
- Archana Mishra (ORCID: https://orcid.org/0000-0001-8837-299X)
- Debasish Hota (ORCID: https://orcid.org/0000-0002-7339-1773)
- Rituparna Maiti (ORCID: https://orcid.org/0000-0003-4063-9178)
- Anand Srinivasan (ORCID: https://orcid.org/0000-0002-0663-0922)
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- International Journal of Neuroscience
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1080/00207454.2025.2489701
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00